Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DSAM Partners is a London-based investment management and hedge fund firm, not a biotechnology, pharmaceutical, or healthcare operating company. Publicly available sources describe it as an active private fund manager focused on investment management and fund management activities, with a London entity and an affiliated U.S. entity in New York that historically provided marketing support, trade execution, and investment research. The firm has been associated with equity long-short and broader hedge fund investment strategies rather than the development of therapeutics, diagnostics, or healthcare services. While some professionals associated with DSAM have invested in healthcare and biotechnology sectors, DSAM itself does not appear to be a life sciences company and no drug pipeline or therapeutic platform is publicly attributable to it.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSAM Partners.